(19)
(11) EP 1 651 764 A2

(12)

(88) Date of publication A3:
30.06.2005

(43) Date of publication:
03.05.2006 Bulletin 2006/18

(21) Application number: 04741374.5

(22) Date of filing: 05.08.2004
(51) International Patent Classification (IPC): 
C12N 15/12(1990.01)
 C12N 9/64(1980.01)
(86) International application number:
PCT/EP2004/008798
(87) International publication number:
WO 2005/014804 (17.02.2005 Gazette 2005/07)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 06.08.2003 US 493080 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL 
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventors:
  • BRÜNGGER, Adrian
    CH-4053 Basel (CH)
  • CAI, Richard, Lie
    Weston, MA 02493 (US)
  • KOSSIDA, Sophia
    CH-4056 Basel (CH)
  • PIERRAT, Benoît
    F-68300 Saint-Louis (FR)
  • NIRMALA, Nanguneri, R.
    West Roxbury, MA 02132 (US)

(74) Representative: Roth, Peter Richard 
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) UBIQUITIN-SPECIFIC PROTEASE